[Palliative combined chemotherapy in patients with inoperable primary liver cancer].
The subjective, objective evidences of status of 61 patients with primary liver cancer were studied. The patients were divided into two groups. The first group underwent a course of chemotherapy, the second group--combined chemotherapy with ericsin as an immunomodulator. Decrease of pain sensation, less side effects of treatment, improvement of general state and life style of the patients were observed in the second group thus giving us an opportunity to run refresher courses of treatment.
Pulatov
D A
DA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D017821:Boidae; D017024:Chemotherapy, Adjuvant; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods*; D014020:Tissue Extracts / Q000008:administration & dosage / Q000627:therapeutic use*
D014020:Tissue Extracts; D004317:Doxorubicin; D005472:Fluorouracil